
Please try another search
Alexandria Real Estate Equities, Inc. (NYSE:ARE) is expanding the company’s full-service life-science start-up platform, Alexandria LaunchLabs, with the opening of its first Cambridge location at the Alexandria Center in One Kendall Square (NYSE:SQ). The move comes as part of the company’s expansion efforts to bank on the life-science real estate industry’s favorable fundamentals.
Particularly, the 20,000-square-foot seed- and early-stage incubator opens with more than 10 innovative seed- and early-stage member companies. There is a high demand for this platform, as well as for its prime location in the heart of East Cambridge's Kendall Square, known as the world's most innovative square mile. This is evident from the strong pool of applicants for this facility.
The company will provide flexible, cost-effective, move-in ready and well-equipped wet laboratory and office space. Further, it would offer high-quality equipment and services, mentorship and programming, in addition to seed-capital access through Alexandria Seed Capital Platform.
Notably, with its prized site at the Alexandria Center for Life Science – New York City and Cambridge location at the Alexandria Center at One Kendall Square, the company remains well poised to provide a solid start-up platform for life-science companies. This, in turn, will spur demand for life-science space over the long run. Given the company’s expertise and robust balance-sheet capacity, it might capitalize well on the same and ride on its growth curve.
Joel S. Marcus, executive chairman and founder of Alexandria Real Estate Equities, Inc. and Alexandria Venture Investments informed, “Our unique, fully integrated Alexandria LaunchLabs platform and our Alexandria Seed Capital Platform will continue to fill the crucial role in aiding transformative seed- and early-stage companies in their efforts to develop novel, cost-effective therapies to ease human suffering."
Moreover, recently the company announced a 4.3% sequential hike in quarterly cash dividend. In November, Alexandria announced that it has commenced development of a 175,000 rentable square feet (RSF) Class A property on its Maryland campus at 9800 Medical Center Drive. The move comes as part of its effort to enhance property base in key locations.
Notably, strong fundamentals of the life-science industry are helping the company’s Class A properties in upscale locations to enjoy high occupancy. Its effort to improve credit profile is also encouraging. Nonetheless, the company’s huge development pipeline exposes it to the risk of rising construction costs.
Alexandria currently carries a Zacks Rank #3 (Hold). Over the past month, shares of the company have inched up 0.3%, outperforming the industry’s 0.8% decline during the same time period.
US stock indices got a new impulse to decline on Friday on fears about the viability of Deutsche Bank (ETR:DBKGn). This is the recent momentum of the banking stress we have been in...
S&P E-mini pre-open market analysis The E-mini S&P 500 futures may go sideways today after market rallied yesterday for the first couple of hours and then sold off in a strong...
Is it time for us contrarians to “buy the dip” in bank stocks? We’re drowning in big bank-scare headlines. Silicon Valley Bank (SIVB) knuckled under in days,...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.